Nikolac Nora, Krleza Jasna Lenicek, Simundic Ana-Maria
University Department of Chemistry, Medical School University Hospital Sestre Milosrdnice, Zagreb, Croatia; Working group for preanalytical phase, Croatian Society of Medical Biochemistry and Laboratory Medicine, Zagreb, Croatia.
Department of laboratory diagnostics, Children's hospital Zagreb, Croatia; CROQALM, Croatian Society of Medical Biochemistry and Laboratory Medicine, Zagreb, Croatia.
Biochem Med (Zagreb). 2017 Feb 15;27(1):131-143. doi: 10.11613/BM.2017.017.
The aim of this paper is to present results of first two years of preanalytical external quality assessment (EQA) in Croatia.
This paper summarizes results from 6 rounds of preanalytical EQA during 2014-2016 in 161-175 Croatian laboratories (number ranged between cycles). EQA was designed as an online survey of the compliance with National recommendations for phlebotomy (NRP). Forty-seven questions in 5 categories are analyzed (materials and equipment, patient identification, patient preparation, sampling and storage). Additionally, preanalytical cases are presented. Overall performance scores (Question score (Qscore) for compliance with NRP and Case score (Cscore) for preanalytical cases) are calculated for each question/case as a proportion of laboratories with satisfactory procedure (x 100). Qscores and Cscores ≥ 70 were classified as acceptable (maximal score = 100).
In investigation of compliance with NRP, acceptable Qscores were obtained for 34/47 questions. The lowest scores were observed for the availability of sterile disposable tourniquets (Qscore = 15) and safe-sharp needles (Qscore = 34), obtaining patients address as an identifier (Qscore = 21), using glycolysis inhibitor tubes for glucose concentration measurement (Qscore = 21) and verification of manufacturers declarations on temperature and time of storage (Qscore = 31). There was no statistically significant difference in overall Qscore according to different categories of phlebotomy procedures (P = 0.284). The results of preanalytical cases showed acceptable Cscore values for all cases (89-96).
First two years of preanalytical EQA showed good compliance with the NRP and excellent expertise in resolving complex preanalytical issues. Major critical spots are lack of availability of safe-sharp needles, disposable tourniquets and glucose inhibitor tubes.
本文旨在展示克罗地亚前两年分析前外部质量评估(EQA)的结果。
本文总结了2014 - 2016年期间在161 - 175家克罗地亚实验室(各轮次数量有所不同)进行的6轮分析前EQA的结果。EQA设计为一项关于静脉穿刺术国家建议(NRP)合规情况的在线调查。对5个类别中的47个问题进行了分析(材料与设备、患者识别、患者准备、采样与储存)。此外,还展示了分析前的案例。为每个问题/案例计算总体表现得分(符合NRP的问题得分(Qscore)和分析前案例的案例得分(Cscore)),作为程序令人满意的实验室比例(×100)。Qscore和Cscore≥70被归类为可接受(满分 = 100)。
在对NRP合规性的调查中,47个问题中有34个获得了可接受的Qscore。无菌一次性止血带的可用性(Qscore = 15)、安全锐器针(Qscore = 34)、获取患者地址作为标识符(Qscore = 21)、使用糖酵解抑制剂管进行葡萄糖浓度测量(Qscore = 21)以及核实制造商关于储存温度和时间的声明(Qscore = 31)得分最低。根据不同类别的静脉穿刺术程序,总体Qscore没有统计学显著差异(P = 0.284)。分析前案例的结果显示所有案例的Cscore值均可接受(89 - 96)。
分析前EQA的前两年显示出对NRP的良好合规性以及解决复杂分析前问题的出色专业能力。主要关键问题是安全锐器针、一次性止血带和葡萄糖抑制剂管的供应不足。